دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 1 نویسندگان: Juan G. Puig, Felicitas A. Mateos, Teresa Sancho, Rosa J. Torres, Antonio Buño (auth.), Andrea Griesmacher, Mathias M. Müller, Peter Chiba (eds.) سری: Advances in Experimental Medicine and Biology 431 ISBN (شابک) : 9781461374565, 9781461553816 ناشر: Springer US سال نشر: 1998 تعداد صفحات: 815 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 21 مگابایت
کلمات کلیدی مربوط به کتاب متابولیسم پورین و پیریمیدین در مرد IX: بیوشیمی، عمومی، فارماکولوژی / سم شناسی، آناتومی حیوانات / مورفولوژی / بافت شناسی
در صورت تبدیل فایل کتاب Purine and Pyrimidine Metabolism in Man IX به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب متابولیسم پورین و پیریمیدین در مرد IX نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
امین این جلد شامل مقالات ارائه شده در نهمین سمپوزیوم مشترک بین المللی و ششمین سمپوزیوم اروپایی در مورد متابولیسم پورین و پیریمیدین در انسان است که در گموندن، اتریش، از 1 تا 7 ژوئن 1997 برگزار شد. در اسراییل در سال 1973، هر سه سال یکبار کنوانسیون هایی در نقاط مختلف جهان از جمله ایالات متحده آمریکا، ژاپن و اروپا تشکیل می شد. جنبه های مختلف متابولیسم پورین و پیریمیدین، جستجوگرانی را که در زمینه ژنتیک مولکولی، فارماکولوژی بیوشیمیایی، بیوشیمی، زیست شناسی، ایمنی شناسی، اپیدمیولوژی و کلینیک ها کار می کنند، گرد هم می آورد. تحقیقات متمرکز در این زمینه برای توسعه داروهای ضد سرطان و ضد ویروسی قوی بوده است. با افزایش تعداد ژن هایی که شبیه سازی می شوند، درک متابولیسم به طور فزاینده ای افزایش می یابد و ممکن است منجر به بهبود بیشتر مفاهیم درمانی و درک بهتر مکانیسم های مسئول ایجاد مقاومت در برابر این داروها شود. در برخی بیماری ها، آنالوگ های پورین و پیریمیدین نه تنها داروهای انتخابی هستند، بلکه در واقع تنها جایگزین درمانی در حال حاضر هستند. این رشته همچنین در تلاش برای تصحیح خطاهای ذاتی متابولیسم پورین و پیریمیدین توسط ژن درمانی پیشرو بوده است. تشکیل این نشست شامل تعداد زیادی از مردم بود که وقت خود را برای موفقیت این سمپوزیوم اختصاص دادند. ما از کمیته بررسی چکیده، هیئت مشورتی بین المللی و به ویژه دبیرخانه سمپوزیوم برای انجام کار فوق العاده تشکر می کنیم.
th th This volume comprizes articles presented at the joint IX International and 6 Euro pean Symposium on Purine and Pyrimidine Metabolism in Man held in Gmunden, Austria, June 1 through 7, 1997. Since the first of this series of meetings was held in Israel in 1973, conventions were organized every three years in different parts of the world including the USA, Japan, and Europe. The different aspects of purine and pyrimidine metabolism bring together re searchers working in molecular genetics, biochemical pharmacology, biochemistry, devel opmental biology, immunology, epidemiology and the clinics. Oriented research in the field has been seminal for the development of potent anticancer and antiviral drugs. As the number of genes which are cloned, grows, the understanding of metabolism is increas ingly enlarged and might provide leads to further improve therapeutic concepts and to bet ter understand mechanisms responsible for the development of resistance against these drugs. In certain diseases purine and pyrimidine analogs represent not only the drugs of choice but in fact are the sole therapeutic alternative at present. The field has also taken an early lead in attempting to correct inborn errors of purine and pyrimidine metabolism by gene therapy. The organization of this meeting involved a large number of people who dedicated their time in an effort to make this symposium a success. We thank the Abstract Review Committee, the International Advisory Board and in particular the Symposium Secretariat for doing a wonderful job.
Front Matter....Pages i-xxiii
Front Matter....Pages xxv-xxv
Gout New Questions for an Ancient Disease....Pages 1-5
Efficacy of Allopurinol in Ameliorating the Progressive Renal Disease in Familial Juvenile Hyperuricaemic Nephropathy (FJHN)....Pages 7-11
Optimal Range of Serum Urate Concentrations to Minimize Risk of Gouty Attacks During Anti-Hyperuricemic Treatment....Pages 13-18
How Should we Treat Tophaceous Gout in Patients with Allopurinol Hypersensitivity?....Pages 19-23
The Spectrum of HGPRT Deficiency....Pages 25-29
Plasma Uridine as well as Uric Acid is Elevated Following Fructose Loading....Pages 31-35
Inverse Relationship Between Serum Triglyceride Levels and Fractional Urate Excretion....Pages 37-40
Microanalysis of Pathological Crystals and Urinary Calculi....Pages 41-45
Zonal Distribution of Allopurinol-Oxidizing Enzymes in Rat Liver....Pages 47-50
Severe Debilitating Polyarticular Gout and Terminal Renal Failure in an Allopurinol ‘Non-Responder’....Pages 51-55
Decreased Serum Concentrations of 1,25(OH)2-Vitamin D3 in Patients with Gout....Pages 57-60
Lipoproteins in Patients with Isolated Hyperuricemia....Pages 61-67
Atherogenic Risk Factors in Patients with Gout....Pages 69-72
Mast Cell Adenosine Receptor Characteristics and Signaling....Pages 73-78
Purine and Pyrimidine Nucleoside Content of the Neuronal Extracellular Space in Rat....Pages 79-82
Effect of FMLP Stimulation on [ 3 H]-NECA Binding to Adenosine Receptors in Neutrophils Membranes....Pages 83-87
Effects of Nucleoside Transport Inhibitors and Adenine/Ribose on ATP Concentration and Adenosine Production in Cardiac Myocytes....Pages 89-94
Purification of a Protein Involved in ADP Formation....Pages 95-98
ADP Formation In Rat Liver....Pages 99-102
A 1 Adenosine Receptors in Human Neutrophils....Pages 103-105
Purification and Some Molecular Properties of Pigeon Heart AMP-Selective 5′-Nucleotidase....Pages 107-111
Succinylpurines do not Modify Glutamate or Adenosine Effects in the CNS....Pages 113-117
Clinical and Biochemical Aspects of Dihydropyrimidinase Deficiency....Pages 119-123
The Genetic Basis of Myoadenylate Deaminase Deficiency is Heterogeneous....Pages 125-128
The Origin of APRT*J the Most Common Disease-Related Mutation of APRT Gene Among Japanese Goes Back to a Prehistoric Era....Pages 129-133
HGPRT and Aprt Activities in Hemolysates During the First Year of Life....Pages 135-139
Delayed Hypersensitivity to 5-Fluorouracil Associated with Reduced Dihydropyrimidine Dehydrogenase (DPD) Activity....Pages 141-145
HPRT-Mutations in Italian Lesch-Nyhan Patients....Pages 147-150
Erythrocyte Cdp-Choline Accumulation in Haemolytic Anaemia and Renal Failure (Rf)....Pages 151-153
Erythrocyte UMP Synthetase Activity....Pages 155-159
Nonrandom Selection of Hair Follicles in HPRT Heterozygosity....Pages 161-165
Optimised Micellar Electrokinetic Capillary Chromatography of UV-Absorbing Compounds in Urine....Pages 167-170
Effect of D-Ribose Administration to a Patient with Inherited Deficit of Adenylosuccinase....Pages 171-176
Enzyme Activities Leading to NAD Synthesis in the Erythrocytes of Hprt Deficient Subjects....Pages 177-180
Succinylpurines Induce Neuronal Damage in the Rat Brain....Pages 181-184
Urinary Screening for Pyrimidine Metabolism Disorders....Pages 185-189
Carrier State in Hgprt Deficiency a Study in 14 Spanish Families....Pages 191-195
Genetic Diagnosis of Hypoxanthine-Guanine Phosphoribosyltransferase (Hgprt) Carrier Status by Restriction Analysis and Directed Mutagenesis....Pages 197-200
Muscle Purine Nucleotide Cycle Enzymes in Exercise Intolerance....Pages 201-204
Prenatal Diagnosis of HPRT Mutant Genes in Lesch-Nyhan Syndrome....Pages 205-209
Regulation of Human PRS Isoform Expression....Pages 211-214
Structure and Functional Relationships in Human pur H....Pages 215-220
Localization of Carbamoyl-Phosphate Synthetase II (Cps Ii) and Aspartate Carbamoyltransferase (Act) Genes in trypanosoma Cruzi Chromosomal DNA....Pages 221-226
Expression and Characterization of Recombinant Bovine Cytosolic 5′-Nucleotidase IMP-GMP Specific....Pages 227-230
Molecular Characterization of a Carbamoyl-Phosphate Synthetase II (Cps II) Gene from leishmania Mexicana ....Pages 231-235
Substrate Channelling by Human IMP Synthase....Pages 237-240
Inhibition of Adenylosuccinate Lyase By 2′, 3′-Acyclic Substrate Analogs....Pages 241-244
Regulation of Deoxycytidine Kinase by Deoxycytidine and Deoxycytidine 5′ Triphosphate in Whole Leukemia and Tumor Cells....Pages 245-248
Kinetic Properties of CTP Synthetase from Hl-60 Cells....Pages 249-253
cellulomonas sp . Purine Nucleoside Phosphorylase (PNP)....Pages 255-258
Subdomain Structure of Carbamyl Phosphate Synthetase....Pages 259-264
The Effects of Nucleotide Pool on Purine Production in the Postischemic Heart....Pages 265-269
Muscle Energy Metabolism in Human Adenylosuccinase Deficiency....Pages 271-274
Cardioprotection by Ischemic Preconditioning....Pages 275-278
High-Energy Phosphate Changes in the Normal and Hypertrophied Heart During Cardioplegic Arrest and Ischemia....Pages 279-282
Role of Glutamate-67 in the Catalytic Mechanism of Human Cytidine Deaminase....Pages 283-286
Heterozygosity for a Point Mutation in an Invariant Splice Donor Site of Dihydropyrimidine Dehydrogenase and Severe 5-Fluorouracil Related Toxicity....Pages 287-291
Site Directed Mutagenesis of the saccharomyces Cerevisiae Apt1 Gene....Pages 293-298
Studies on Cysteine Residues Involved in the Active Site of Human Cytidine Deaminase....Pages 299-303
Relationship of the Two APRT Gene Products from saccharomyces Cerevisiae ....Pages 305-308
Structural and Functional Analysis of the Human TPMT Gene Promoter....Pages 309-314
A First Evidence of an Asymptomatic Germline Missense Base Substitution in the Hypoxanthine Phosphoribosyltransferase (HPRT) Gene in Humans....Pages 315-318
Genetic Basis of Adenylosuccinase Deficiency in an Italian Patient....Pages 319-322
Mutations in Xanthine Dehydrogenase Gene in Subjects with Hereditary Xanthinuria....Pages 323-325
Role of Cysteine and Lysine Residues in Human Hypoxanthine-Guanine Phosphoribosyltransferase....Pages 327-330
Molecular Analysis of Mouse ampd3 Gene Encoding Heart-Type Isoform of Amp Deaminase....Pages 331-335
Dihydropyrimidine Dehydrogenase Deficiency....Pages 337-340
Gene Mutations Responsible for Human Erythrocyte AMP Deaminase Deficiency in Poles....Pages 341-346
Response of Purine Metabolism to Hypoxia and Ischemia....Pages 347-350
Endothelial Purine Metabolism and Reperfusion Injury....Pages 351-357
Adenosine-Induced Preconditioning of Rat Neuronal Cultures Against Ischemia-Reperfusion Injury....Pages 359-364
Myocardial Ischemic Injury During Cardio-Pulmonary by-Pass....Pages 365-368
Nucleotide Metabolism in the Heart Subjected to Heat Stress....Pages 369-372
Differences in Nucleotide Metabolism and Mechanical Recovery after Cardioplegic Arrest of the Heart at Different Age....Pages 373-376
Different Mechanism of Myocardial Nucleotide Breakdown During Normothermic and Hypothermic Ischemia....Pages 377-379
Effects of Adenine/Ribose Supply on Adenosine Production and ATP Concentration in Adenosine Kinase Inhibited Cardiac Cells....Pages 381-383
A Nucleotide and Nucleosides Mixture Solution Improves Recovery of Energy Metabolism after Hepatic Ischemia in Rats....Pages 385-388
Can Adenosine Deaminase Inhibitors be Cytoprotective Agents?....Pages 389-393
Role of Purine Metabolism in Regulation of Signal Transduction in Human Carcinoma Cells....Pages 395-399
Role Of Adenosine Deaminase and dATP Levels in Thymocyte Apoptosis....Pages 401-408
Structure and Function of P2Y 2 Nucleotide Receptors in Cystic Fibrosis (CF) Epithelium....Pages 409-415
Deoxycytidine Kinase can be also Potentiated by the G-Protein Activator NaF in Cells....Pages 417-424
Low GTP Induces PKC-β-Dependent Myeloid Cell Differentiation....Pages 425-428
Exogenous S-Adenosyl-Methionine Methylates Phospholipids Located on the Outer Cell Surface of Isolated Rat Hepatocytes....Pages 429-432
Imp-Dehydrogenase (IMPDH), Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT), and Phosphodiesterases (PDEs) Expression During Mycophenolic Acid (MPA)-Induced Differentiation in Human Neuroblastoma Cell Lines....Pages 433-437
Differentiating and Biochemical Effects of a Reduction of Intracellular GTP Levels Induced by Mycophenolic Acid (MPA) in Human Neuroblastoma (NB) Cell Lines....Pages 439-441
New Models for the Study of Adenosine Deaminase Deficiency....Pages 443-446
Insights into Adenosine Deaminase Deficiency Provided by Murine Fetal Thymic Organ Culture with 2′-Deoxycoformycin....Pages 447-449
Thymidine Kinase Expression....Pages 451-454
Neuroblastoma Cell Apoptosis Induced by Mycophenolic Acid....Pages 455-460
The Single Deoxynucleoside Kinase in Drosophila Melanogaster, Dm -dnk, is Multifunctional and Differs from the Mammalian Deoxynucleoside Kinases....Pages 461-464
Effect of Deoxynucleosides on the Repair of UV Induced DNA Breaks....Pages 465-469
A New Model Organism for Studying the Catabolism of Pyrimidines and Purines....Pages 471-474
Cad Overexpression in Mammalian Cells....Pages 475-479
Azathioprine Treatment and Thiopurine Metabolism in Rheumatic Diseases....Pages 481-485
Identification of Multiple forms of the Cytosolic 5′-Nucleotidase/Phosphotransferase in Rat Tissues....Pages 487-493
Regulation of Deoxynucleotide Pools by Substrate Cycles....Pages 495-499
Dihydroorotate Dehydrogenase....Pages 501-506
Purine Nucleoside Phosphorylase Deficient Mice Exhibit Both an Age Dependent Attrition of Thymocytes and Impaired Thymocyte Differentiation....Pages 507-513
Activation of Deoxycytidine Kinase During Inhibition of DNA Synthesis in Human Lymphocytes....Pages 515-518
Similar Changes Were Induced by Cladribine and by Gemcitabine, in the Deoxypyrimidine Salvage, During Short Term Treatments....Pages 519-523
Effect of Cladribine, Fludarabine, and 5-AZA-Deoxycytidine on S-Adenosylmethionine (SAM) and Nucleotides Pools in Stimulated Human Lymphocytes....Pages 525-529
Inhibition of Inosine Monophosphate Dehydrogenase Activity by the Plasma of Heart Transplant Recipients Receiving Mycophenolate Mofetil....Pages 531-535
Changes of Polymorphonuclear Leukocyte (PMN) Functions Under Dietary Nucleic Acid Deficiency and Effects of Administration of Nucleotide and Nucleosides Mixture Solution in Mice....Pages 537-541
Differentiation and Reduction of Intracellular GTP Levels in Hl-60 and U937 Cells Upon Treatment with IMP Dehydrogenase Inhibitors....Pages 543-547
Isoenzymes of 5′-Nucleotidase in Human Lymphocytes....Pages 549-553
Biochemical Basis for the Impaired Immune Response in Chronic Renal Failure?....Pages 555-558
Mycophenolic Acid Influences the Expression of ICAM-1 on Human Endothelial Cells....Pages 559-563
Reaction of 2′, 3′-Dideoxynucleotides Triphosphates with Recombinant Human Nucleoside Diphosphate Kinase....Pages 565-568
Antitumor Activity of Yunnanmycin....Pages 569-573
Mechanisms of Synergism Between Gemcitabine and Cisplatin....Pages 575-579
Cross-Resistance of the Gemcitabine Resistant Human Ovarian Cancer Cell Line AG6000 to Standard and Investigational Drugs....Pages 581-585
Increased Sensitivity to Gemcitabine of P-gP and MRP Overexpressing Human Non-Small Cell Lung Cancer Cell Lines....Pages 587-590
Does 2-Chlorodeoxyadenosine Contribute to Alteration of DNA Methyltransferase Activity?....Pages 591-594
Iron Binding Capacity of Didox (3,4 Dihydroxybenzohydroxamic Acid) and Amidox (3,4 Dihydroxybenzamidoxime) two Inhibitors of the Enzyme Ribonucleotide Reductase....Pages 595-598
In Vitro and in Vivo Inhibitory Activity of the Differentiation-Inducing Agent 9-(2-Phosphonylmethoxyethyl)Adenine (Pmea) Against Rat Choriocarcinoma....Pages 599-604
Increased Cell Killing and Mutagenecity by DNA Alkylating Agents in Cells with Decreased TTP Pools....Pages 605-609
N 4 -Hydroxy-5-Halogeno-2′-Deoxycytidine S and Their 5′-Mono-Phosphates as Inhibitors of Thymidylate Synthase and in Vitro Antileukemic Agents....Pages 611-616
Substrate/Inhibitor Specificities of Human Deoxycytidine Kinase (DCK) and Thymidine Kinases (TK1 and TK2)....Pages 617-621
Investigation of Isoenzymes of Adenylosuccinase in Human Blood Cells....Pages 623-627
Dihydropyrimidine Dehydrogenase in Livers from Mouse and Rat, and in Human Liver, Colon Tumors, and Mucosa in Relation to Anabolism of 5-Fluorouracil....Pages 629-632
Induction of in Vivo Resistance Against Gemcitabine (dFdC,2′,2′-Difluoro-Deoxycytidine)....Pages 633-636
Activation of Deoxycytidine Kinase by Various Nucleoside Analogues....Pages 637-640
Clinical Pharmacology of Intermediate and Low-Dose Cytosine Arabinoside (ara-C) Therapy in Patients with Hematologic Malignancies....Pages 641-645
The Role of Thymidine Kinase Activity in Murine Colon Tumours Treated with 5-Fluorouracil....Pages 647-651
Role of Deoxycytidine Kinase (dCK), Thymidine Kinase 2 (TK2), and Deoxycytidine Deaminase (dCDA) in the Antitumor Activity of Gemcitabine (dFdC)....Pages 653-656
Differential Effects of Gemcitabine on Nucleotide Pools of 19 Solid Tumor Cell Lines....Pages 657-660
Increased Activity of Cytidine triphosphate Synthetase in Pediatric Acute Lymphoblastic Leukemia....Pages 661-665
Expression of Human Cytosolic Thymidine Kinase in Escherichia Coli ....Pages 667-671
Structure-Activity Relationship in Ftorafur (Tegafur) and Related 5-Fu Prodrugs....Pages 673-676
Measurement of Mutation Frequency at the HPRT Locus in Peripheral Lymphocytes....Pages 677-680
Thiopurine Treatment in Childhood Leukemia....Pages 681-686
Relationship Between Cladribine (CDA) Plasma, Intracellular Cda-5′-Triphosphate (CDATP) Concentration, Deoxycytidine Kinase (DCK), and Chemotherapeutic Activity in Chronic Lymphocytic Leukemia (CLL)....Pages 687-692
Determinants of the Therapeutic Efficacy of Thymidylate Synthase Inhibitors....Pages 693-697
Pyrimidine Antagonists and Antifolates as Antimalarial Drugs....Pages 699-704
Adenine Nucleoside Phosphorylases in Trematode Fasciola Hepatica , the Mammalian Parasite....Pages 705-709
Inhibition by 3′-Azido-3′-Deoxythymidine (AZT) of trypanosoma Cruzi Growth in Mammalian Cells and a Possible Mechanism of Action....Pages 711-717
Metabolism of Eicar (5-Ethynyl-1-β-D- Ribofuranosylimidazole-4-Carboxamide),A Potent Inhibitor of Inosinate Dehydrogenase....Pages 719-722
A HPLC Method for the Monitoring of Human Red Cell 6-Thioguanine and Methyl 6-Mercaptopurine in a Single Run....Pages 723-728
Expression and Properties of Recombinant P. Falciparum Hypoxanthine-Guanine Phosphoribosyltransferase....Pages 729-734
Determination of Thiopurine Methyltransferase Activity in Erythrocytes Using 6-Thioguanine as the Substrate....Pages 735-739
Antiviral Acyclic Nucleoside Phosphonate Analogues as Inhibitors of Purine Nucleoside Phosphorylase....Pages 741-745
Metabolism and Anti-HIV Activity of Phosphoramidate Derivatives of D4T-MP with Variations in the Amino Acid Moiety....Pages 747-752
Determination of Purine Enzyme Activities in Human Erythrocytes by Capillary Electrophoresis....Pages 753-757
Capillary Electrophoretic Analysis of Hypoxanthine and Xanthine for the Diagnosis of Xanthinuria....Pages 759-763
Ecto-Nucleotidases in Isolated Intact Rat Vagi, Nodose Ganglia, and Superior Cervical Ganglia....Pages 765-767
Hypoxanthine and Xanthine as Markers in Early Diagnosis of Foetal Diseases....Pages 769-776
Effects of Dipyridamole and Adenine/Ribose on ATP Concentration and Adenosine Production in Cardiac Myocytes....Pages 777-780
Evaluation Of Adenine Concentration in Plasma of Patients with Renal Failure Using Improved Ultrafiltration Technique....Pages 781-784
A Syndrome of Seizures and Pervasive Developmental Disorder Associated with Excessive Cellular Nucleotidase Activity....Pages 785-787
de Novo Purine Synthesis is Increased in the Fibroblasts of Purine Autism Patients....Pages 789-792
Determination and Separation of Allantoin, Uric Acid, Hypoxanthine, and Xanthine by Capillary Zone Electrophoresis....Pages 793-796
Pharmacokinetics of Mycophenolate Mofetil in Heart Transplant Recipients....Pages 797-800
Immunohistochemical Analysis of P185 and ASL Activity in Pre-Neoplastic Lesions and Intestinal Mucosa of Human Subjects....Pages 801-803
No Circadian Variation of Dihydropyrimidine Dehydrogenase, Uridine Phosphorylase, β-Alanine, and 5-Fluorouracil During Continuous Infusion of 5-Fluorouracil....Pages 805-809
Subcellular Localization of Dihydropyrimidine Dehydrogenase....Pages 811-816
The Activity of Dihydropyrimidine Dehydrogenase in Human Blood Cells....Pages 817-821
Endothelial Purine Content....Pages 823-826
Influence of Glycopeptide Antibiotics on Purine Metabolism of Endothelial Cells....Pages 827-831
Effect of Tofu (Bean Curd) Ingestion on Uric Acid Metabolism in Healthy and Gouty Subjects....Pages 833-838
Purines and Pyrimidines Determination in Urine Using High-Performance Liquid Chromatography....Pages 839-842
Design, Synthesis, and Structure-Activity Relationships of the First Highly Potent, Selective, and Bio Available Adenosine 5′-Monophosphate Deaminase Inhibitors....Pages 843-848
Design and Synthesis of the First Potent, Selective, and Cell Penetrating Adenosine 5′-Monophosphate Deaminase Inhibitors....Pages 849-852
Erratum to: Effects of Nucleoside Transfort Inhibitors and Adenine/Riboseon ATP Concentration and Adenosine Production in Cardiac Myocytes....Pages 853-857
Erratum to: Energy Metabolism in the Failing Human Heart with Dilated or Hypertrophic Cardiomyopathy.....Pages 867-867
Back Matter....Pages 867-867
....Pages 859-866